Fingerprint Dive into the research topics of ''Neo-FAC' (5-fluorouracil, doxorubicin, and cyclophosphamide) for poor- prognosis stage IV breast cancer: A Southwest Oncology Group phase II study'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically